1. Nowak T. Pathophysiology: Concepts and Applications for Health Care Professionals. 3rd ed. Boston, MA: McGraw-Hill; 2011.
2. Hall J. Guyton and Hall Textbook of Medical Physiology. 13th ed. Philadelphia, PA: Elsevier; 2016.
3. McCance KL, Huether SE. Pathophysiology: The Biologic Basis for Disease in Adults and Children. 8th ed. St. Louis, MO: Mosby; 2018.
5. Brashers VL. Clinical Applications of Pathophysiology: Assessment, Diagnostic Reasoning and Management. 2nd ed. St. Louis, MO: Mosby; 2002.
11. Uddin LQ, Nomi JS, Hebert-Seropian B, Ghaziri J, Boucher O. Structure and finction of the human insula. J Clin Neurophysiol. 2017;34(4):300-306.
12. Grossman SC, Porth CM. Pathophysiology: Concepts of Altered Health States. Philadephia, PA: Lippincott, Williams and Wilkins; 2014.
13. Bruyere HJ Jr. 100 Case Studies in Pathophysiology. Philadelphia, PA: Lippincott, Williams and Wilkins; 2009.
15. Blumenfeld H. Neuroanatomy Through Clinical Cases. 2nd ed. Sunderland, MA: Sinouer Associates; 2010.
16. Mitchell RN, Robbins SL. Pocket Companion to Robbins and Coltran Pathologic Basis of Disease. 8th ed. Philadelphia, PA: Saunders; 2012.
18. Ackley BJ, Ladwig GB, Flynn Makic MB. Nursing Diagnosis Handbook: An Evidence-Based Guide to Planning Care. 11th ed. St. Louis, MO: Elsevier; 2017.
19. Ladwig GE, Ackley B, Flynn Makic MB. Mosby's Guide to Nursing Diagnosis. 5th ed. St. Louis, MO: Elsevier; 2016.
20. Barkauskas VH, Baumann LC, Darling-Fisher CS. Health and Physical Assessment. 3rd ed. St. Louis, MO: Mosby; 2002.
21. Campbell WW, Dejong RN. DeJong's The Neurologic Examination. 7th ed. Philadelphia, PA: Wolters Klower; 2012.
22. Rowland MD. Merritt's Neurology. 11th ed. Philadelphia, PA: Lippincott, Williams, and Wilkins; 2005.
23. Rae-Grant A. Weiner and Levitt's Neurology. 8th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2008.
25. Gulanick. Nursing Care Plans: Diagnoses, Interventions, and Outcomes. 9th ed. St. Louis, MO: Elsevier Health Sciences; 2017.
29. Black JM, Hawks JH, Luckmann J. Medical Surgical Nursing: Clinical Management for Positive Outcomes. 8th ed. Philadelphia, PA: W.B. Saunders; 2009.
30. LeMone P. Medical Surgical Nursing: Critical Thinking in Client Care. 5th ed. Boston, MA: Pearson; 2014.
31. Eunice Kennedy Shriver National Institute of Child Health and Human Development. What are Common Treatments for Cerebral Palsy? Available at https://www.nichd.nih.gov/health/topics/cerebral-palsy/conditioninfo/treatments. Last accessed October 23, 2024.
32. Saft C, Burgunder JM, Dose M, et al. Differential diagnosis of chorea (guidelines of the German Neurological society). Neurol Res Pract. 2023;5(63):1-11.
35. Galvagno SM. Emergency Pathophysiology: Clinical Applications for Prehospital Care. Jackson, WY: Teton NewMedia; 2013.
36. Berg SM, Bittner EA. Massachusetts General Hospital Review of Critical Care Medicine. Philadephia, PA: Wolters Kluwer, Lippincott, Williams & Wilkins; 2014.
37. Baird MS. Manual of Critical Care Nursing: Nursing Interventions and Collaborative Management. 7th ed. St. Louis, MO: Mosby; 2016.
38. Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics—2023 update: a report from the American Heart Association. Circulation. 2023;147:e93-e621.
39. National Heart, Lung, and Blood Institute. Prevalence of Cardiovascular, Lung, Blood, and Sleep Conditions or Disorders in the U.S. by Number of Americans Affected. Available at https://www.nhlbi.nih.gov/research/data/prevalence. Last accessed October 23, 2024.
40. Broderick JP, Brott T, Tomsick T, Miller R, Huster G. Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage. J Neurosurg. 1993;78(2):188-191.
41. Manno EM, Atkinson JL, Fulgham JR, Wijdicks EF. Emerging medical and surgical management strategies in the evaluation and treatment of intracerebral hemorrhage. Mayo Clin Proc. 2005;80(3):420-433.
42. Shah QA, Ezzeddine MA, Qureshi AI. Acute hypertension in intracerebral hemorrhage: pathophysiology and treatment. J Neurol Sci. 2007;261(1-2):74-79.
43. Greenberg SM, Ziai WC, Cordonnier C, et al. 2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association/American Stroke Association. Stroke. 2022;53(7):e282-e361.
44. Counsell C, Boonyakarnkul S, Dennis M, et al. Primary intracerebral hemorrhage in the Oxfordshire Community Stroke Project: prognosis. Cerebrovasc Dis. 1995;5:26-34.
45. Flaherty ML, Haverbusch M, Sekar PK, et al. Long-term mortality after intracerebral hemorrhage. Neurology. 2006;66(8):1182-1186.
46. Poon MT, Fonville AF, Al-Shahi Salman R. Long-term prognosis after intracerebral hemorrhage: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2014;85(6):660-667.
48. Qureshi AI, Tuhrim S, Broderick JP, Batjer H, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med. 2001;344:1450-1460.
49. Ritter MA, Droste DW, Hegedüs, et al. Role of cerebral amyloid angiopathy in intracerebral hemorrhage in hypertensive patients. Neurology. 2005;64(7):1233-1237.
50. Kernan WN, Viscoli CM, Brass LM, et al. Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med. 2000;343:1826-1832.
51. Suarez JI, Tarr RW, Selman WR. Aneurysmal subarachnoid hemorrhage. N Engl J Med. 2006;354(4):387-396.
52. van Gijn J, Rinkel GJ. Subarachnoid haemorrhage: diagnosis, causes and management. Brain. 2001;124(Pt 2):249-278.
53. Niewwkamp DJ, de Wilde A, Wermer MJ, Algra A, Rinkel GJ. Long-term outcome after aneurysmal subarachnoid hemorrhage—risks of vascular events, death from cancer and all-cause death. J Neurol. 2014;261(2):309-315.
54. Mayer SA, Kreiter KT, Copeland D, et al. Global and domain-specific cognitive impairment and outcome after subarachnoid hemorrhage. Neurology. 2002;59(11):1750-1758.
55. MedlinePlus. Cerebral Arteriovenous Malformation. Available at https://medlineplus.gov/ency/article/000779.htm. Last accessed October 23, 2024.
56. Flaherty ML, Haverbusch M, Kissela B, et al. Perimesencephalic subarachnoid hemorrhage: incidence, risk factors, and outcome. J Stroke Cerebrovasc Dis. 2005;14(6):267-271.
57. Konczalla J, Kashefiolasl S, Brawanski N, Senft C, Seifert V, Platz J. Increasing numbers of nonaneurysmal subarachnoid hemorrhage in the last 15 years: antithrombotic medication as reason and prognostic factor? J Neurosurg. 2016;124(6):1731-1731.
58. Laukka D, Kkivelev J, Rautio R, et al. Physical exertion as a risk factor for perimesencephalic nonaneurysmal subarachnoid hemorrhage. Brain Behav. 2022;12(9):e2756.
59. Johns Hopkins Medicine. Hydrocephalus. Available at https://www.hopkinsmedicine.org/health/conditions-and-diseases/hydrocephalus. Last accessed October 23, 2024.
60. Muir KW, Buchan A, von Kummer R, Rother J, Baron JC. Imaging of acute stroke. Lancet Neurol. 2006;5(9):755-768.
61. Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344-e418.
62. Jauch EC, Al Kasab S. Ischemic Stroke. Available at https://emedicine.medscape.com/article/1916852-overview. Last accessed October 23, 2024.
63. Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2018;49(3):e46-e99.
64. Birschel P, Ellul J, Barer D. Progressing stroke: towards an internationally agreed definition. Cerebrovasc Dis. 2004;17(2-3):242-252.
65. Hayashi K, Kitagawa N, Takahata H, et al. Endovascular treatment for cervical carotid artery stenosis presenting with progressing stroke: three case reports. Surg Neurol. 2002;58(2):148-154.
66. Du Mesnil de Rochemont R, Sitzer M, Neumann-Haefelin T, Harmjanz A, Berkefeld J. Endovascular recanalization of acute atherothrombotic carotid artery occlusion holds up progressive stroke. Neuroradiology. 2004;46(7):583-586.
67. Rerkasem K, Rothwell PM. Systematic review of the operative risks of carotid endarterectomy for recently symptomatic stenosis in relation to the timing of surgery. Stroke. 2009;40:e564-e572.
68. Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. Stroke. 2021;52(7):e364-e467.
69. Winstein CJ, Stein J, Arena R, et al. AHA/ASA guidelines for adult stroke rehabilitation and recovery: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2016;47(6):e98-e169.
70. Langhorne P, Stott DJ, Robertson L, et al. Medical complications after stroke: a multicenter study. Stroke. 2000;31(6):1223-1229.
71. Giles MF, Rothwell PM. Risk of stroke early after transient ischemic attack: a systematic review and meta-analysis. Lancet Neurol. 2007;6(12):1063-1072.
72. Albers GW, Caplan LR, Easton JD, et al. Transient ischemic attack-proposal for a new definition. N Engl J Med. 2002;347(21):1713-1716.
73. Easton JD, Saver JL, Albers GW, et al. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. Stroke. 2009;40(6):2276-2293.
74. Gladstone DJ. Toward an emergency response to transient ischemic attacks. Postgrad Med J. 2005;117(1):9-14.
76. Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA. 2000;284(22):2901-2906.
78. Henry GL, Johnston SC, Pinkowish MD. Acute neurologic symptoms—TIA, migraine, or something else? Patient Care. 2004;38(3):50-56.
79. Nanda A, Singh NN. Transient Ischemic Attack. Available at https://emedicine.medscape.com/article/1910519-overview. Last accessed October 23, 2024.
80. Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia. 2010;51(4):676-685.
81. Mulley JC, Scheffer IE, Harkin LA, Berkovic SF, Dibbens LM. Susceptibility genes for complex epilepsy. Hum Mol Genetics. 2005;14(R2):R243-R249.
82. Engel J Jr, International League Against Epilepsy. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia. 2001;42(6):796-803.
83. National Institute of Neurological Disorders and Stroke. Epilepsies and Seizures. Available at https://www.ninds.nih.gov/health-information/disorders/epilepsy-and-seizures. Last accessed October 23, 2024.
84. Ko DY, Sahai-Srivastava S. Generalized Tonic-Clonic Seizures. Available at https://emedicine.medscape.com/article/1184608-overview. Last accessed October 23, 2024.
85. Epilepsy Foundation. Types of Seizures. Available at https://www.epilepsy.com/what-is-epilepsy/seizure-types. Last accessed October 23, 2024.
86. Johns Hopkins Medicine. Generalized Seizures. Available at https://www.hopkinsmedicine.org/health/conditions-and-diseases/epilepsy/generalized-seizures. Last accessed October 23, 2024.
87. Centers for Disease Control and Prevention. Epilepsy. Available at https://www.cdc.gov/epilepsy/index.html. Last accessed October 23, 2024.
88. Ko DY. Epilepsy and Seizures. Available at https://emedicine.medscape.com/article/1184846-overview. Last accessed October 23, 2024.
89. Adamolekun B. Seizure Disorders. Available at https://www.merckmanuals.com/professional/neurologic-disorders/seizure-disorders/seizure-disorders. Last accessed October 23, 2024.
90. St. Louis EK, Rosenfeld WE, Bramley T. Antiepileptic drug monotherapy: the initial approach in epilepsy management. Curr Neuropharmacol. 2009;7:77-82.
92. Ehrman J, Gordon PM, Visich PS, Keteyian SJ. Clinical Exercise Physiology. 3rd ed. Champaign, IL: Human Kinetics Publishing; 2013.
93. Scottish Intercollegiate Guidelines Network. Diagnosis and Management of Headache in Adults: A National Clinical Guideline. Edinburgh: Scottish Intercollegiate Guidelines Network; 2008. current
94. World Health Organization. Migraine and Other Headache Disorders. Available at https://www.who.int/en/news-room/fact-sheets/detail/headache-disorders. Last accessed October 23, 2024.
95. The International Classification of Headache Disorders 3rd Edition. Available at https://ichd-3.org/. last accessed October 23, 2024.
96. MedlinePlus. Tension Headache. Available at https://medlineplus.gov/ency/article/000797.htm. Last accessed October 23, 2024.
97. Fuller G, Manford M. Neurology: An Illustrated Colour Text. 3rd ed. Edinburgh: Churchill Livingstone Publisher; 2010.
98. Perret D, Chang EY, Hata J, Chen H, Tribuzio B. The Pain Center Manual. New York, NY: Demos Medical; 2014.
99. National Institute on Aging. Alzheimer's and Dementia. Available at https://www.nia.nih.gov/health/alzheimers-and-dementia. Last accessed October 23, 2024.
100. Alzheimer's Association. 2024 Alzheimer's Disease Facts and Figures. Available at https://www.alz.org/media/Documents/alzheimers-facts-and-figures.pdf. Last accessed October 23, 2024.
101. National Institute on Aging. What Causes Alzheimer's Disease? Available at https://www.nia.nih.gov/health/what-causes-alzheimers-disease. Last accessed October 23, 2024.
102. Alzheimer's Association. Stages of Alzheimer's. Available at https://www.alz.org/alzheimers-dementia/stages. Last accessed October 23, 2024.
103. Kuller LH, Lopez OL, Becker JT, et al. Risk of dementia and death in the long-term follow-up of the Pittsburgh Cardiovascular Health Study–Cognition Study. Alzheimers Dement. 2016;12(2):170-183.
104. Solfrizzi V, Frisardi V, Seripa D, et al. Mediterranean diet in predementia and dementia syndromes. Curr Alzheimer Res. 2011;8(5):520-542.
105. Winslow BT, Onysko MK, Stob CM, Hazlewood KA. Treatment of Alzheimer disease. Am Fam Physician. 2011;83(12):1403-1412.
106. Seltzer B. Cholinesterase inhibitors in the clinical management of Alzheimer's disease: importance of early and persistent treatment. J Int Med Res. 2006;34(4):339-347.
107. National Institute on Aging. How is Alzheimer's Disease Treated? Available at https://www.nia.nih.gov/health/how-alzheimers-disease-treated. Last accessed October 23, 2024.
108. Alzheimer's Association. Medications for Memory, Cognition and Dementia-Related Behaviors. Available at https://www.alz.org/alzheimers-dementia/treatments/medications-for-memory. Last accessed October 23, 2024.
109. Beier MT. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention. Pharmacotherapy. 2007;27(3):399-411.
110. DeMaagd G, Philip A. Parkinson's disease and its management. Part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis. PT. 2015;40(8):504-532.
111. Gazewood JD, Richards DR, Clebak K. Parkinson disease: an update. Am Fam Physician. 2013;87(4):267-273.
112. Williams DR, Litvan I. Parkinsonian syndromes. Continuum (Minneap Minn). 2013;19(5):11890-11212.
113. Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res. 2004;318(1):121-134.
114. Schrag A, Horsfall L, Walters K, Noyce A, Petersen I. Prediagnostic presentations of Parkinson's disease in primary care: a case-control study. Lancet Neurol. 2015;14(1):57-64.
115. Braak H, Bohl JR, Muller CM, et al. Stanley Fahn Lecture 2005: the staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered. Mov Disord. 2006;21(12):2042-2051.
116. Williams DR, Lees AJ. How do patients with parkinsonism present? A clinicopathological study. Intern Med J. 2009;39(1):7-12.
117. Massano J, Bhatia KP. Clinical approach to Parkinson's disease: features, diagnosis, and principles of management. Cold Spring Harb Perspect Med. 2012;2(6):a008870.
118. Mhyre TR, Boyd JT, Hamill RW, Maguire-Zeiss KA. Parkinson's disease. Subcell Biochem. 2012;65:389-455.
119. Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015;30(12):1591-1599.
120. Jenner P. Treatment of the later stages of Parkinson's disease: pharmacological approaches now and in the future. Transl Neurodegener. 2015;4:3.
121. Zane RD, Kosowsky JM. Pocket Emergency Medicine. 3rd ed. Philadelphia, PA: Wolters Kluwer; 2015.
122. Markovchick VJ, Pons PT, Bakes KM, Buchanan JA. Emergency Medicine Secrets. 6th ed. Philadelphia, PA: Elsevier; 2016.
123. Bedlack RS, Mitsumoto H. Amyotrophic Lateral Sclerosis: A Patient Care Guide for Clinicians. New York, NY: Demos Medical; 2013.
124. Saitoh Y, Takahashi Y. Riluzole for the treatment of amyotrophic lateral sclerosis. Neurodegener Dis Manag. 2020;10(6):343-355.
126. Zerwekh JA, Claborn JC. Mosby's Pharmacology Memory Notecards. 4th ed. St. Louis, MO: Elsevier; 2015.
127. National Institutes of Health. Myasthenia Gravis. Available at https://www.ninds.nih.gov/sites/default/files/migrate-documents/myasthenia_gravis_e_march_2020_508c.pdf. Last accessed October 23, 2024.
129. AstraZeneca. Ultomiris Approved in the US for Adults With Generalised Myasthenia Gravis. Available at https://www.astrazeneca.com/media-centre/press-releases/2022/ultomiris-approved-in-the-us-for-adults-with-generalised-myasthenia-gravis.html#. Last accessed October 23, 2024.
130. Meglio M. FDA Approves Ravulizumab for Adults with Generalized Myasthenia Gravis. Available at https://www.neurologylive.com/view/fda-approves-ravulizumab-adults-with-generalized-myasthenia-gravis. Last accessed October 23, 2024.
132. Koch-Henriksen N, Sørensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. 2010;9(5):520-532.
133. Frohman TC, O'Donoghue DL, Northrop D (eds). Multiple Sclerosis for the Physician Assistant: A Practical Primer. New York, NY: National Multiple Sclerosis Society; 2011.
134. National Multiple Sclerosis Society. Multiple Sclerosis Symptoms. Available at https://www.nationalmssociety.org/understanding-ms/what-is-ms/ms-symptoms. Last accessed October 23, 2024.
135. Hersh CM, Fox RJ. Disease Management: Multiple Sclerosis. Available at https://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/neurology/multiple_sclerosis/Default.htm. Last accessed October 23, 2024.
136. Rae-Grant A, Day GS, Marrie RA, et al. Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2018;90(17):777-788.
137. MedlinePlus. Interferon Beta-1b Injection. Available at https://medlineplus.gov/druginfo/meds/a601151.html. Last accessed October 23, 2024.
138. MedlinePlus. Interferon Beta-1a Subcutaneous Injection. Available at https://medlineplus.gov/druginfo/meds/a604005.html. Last accessed October 23, 2024.
139. MedlinePlus. Interferon Beta-1a Intramuscular Injection. Available at https://medlineplus.gov/druginfo/meds/a693040.html. Last accessed October 23, 2024.
140. Hickey JV. The Clinical Practice of Neurological and Neurosurgical Nursing. 7th ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2014.
141. Genetic and Rare Diseases Information Center. Herpes Simplex Encephalitis. Available at https://rarediseases.info.nih.gov/diseases/6649/herpes-simplex-encephalitis. Last accessed October 23, 2024.
142. Icahn School of Medicine at Mount Sinai. Viral Encephalitis. Available at https://www.mountsinai.org/health-library/report/viral-encephalitis. Last accessed October 23, 2024.
143. Buttaro T, Trybulski J, Polgar-Bailey P, Sandberg-Cook J. Primary Care: A Collaborative Practice. 5th ed. St. Louis, MO: Elsevier; 2017.
144. Domino FJ. The 5-Minute Clinical Consult Standard 2016. 24th ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2015.
145. Chen N, Li Q, Yang J, Zhou M, Zhou D, He L. Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev. 2014;(2):CD006866.
146. LexiDrug. Available at https://online.lexi.com. Last accessed October 23, 2024.
1. Brown MD, Burton JH, Nazarian DJ, Promes SB, American College of Emergency Physicians. Clinical policy: use of intravenous tissue plasminogen activator for the management of acute ischemic stroke in the emergency department. Ann Emerg Med. 2015;66(3):322-333. Available at https://www.acep.org/siteassets/new-pdfs/clinical-policies/tpa-for-stroke_new.pdf. Last accessed November 7, 2024.
2. Krumholz A, Wiebe S, Gronseth GS, et al. Evidence-based guideline: management of an unprovoked first seizure in adults: report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2015;84(16):1705-1713. Available at https://www.aan.com/Guidelines/home/GetGuidelineContent/688. Last accessed November 7, 2024.
3. Douglas AC, Wippold FJ II, Broderick DF, et al. ACR Appropriateness Criteria: Headache. Reston, VA: American College of Radiology; 2022. Available at https://acsearch.acr.org/docs/69482/Narrative. Last accessed November 7, 2024.
4. Fletcher K. Nursing Standard of Practice Protocol: Recognition and Management of Dementia. Abstract available from Guideline Central at https://www.guidelinecentral.com/guideline/7133/pocket-guide/300908. Last accessed November 7, 2024.
5. Parkinson's Foundation. Parkinson's Exercise Recommendations. 2021. Available at https://www.parkinson.org/sites/default/files/documents/professional-exercise-guidelines.pdf. Last accessed November 7, 2024.
6. Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162-173. Available at https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(17)30470-2/fulltext. Last accessed November 7, 2024.
7. Theodore N, Aarabi B, Dhall SS, et al. Transportation of patients with acute traumatic cervical spine injuries. In: Guidelines for the management of acute cervical spine and spinal cord injuries. Neurosurgery. 2013;72(Suppl 2):35-39. Available at https://journals.lww.com/neurosurgery/fulltext/2013/03002/methodology_of_the_guidelines_for_the_management.5.aspx. Last accessed November 7, 2024.
Mention of commercial products does not indicate endorsement.